Enhanced deposition of cartilage oligomeric matrix protein is a common feature in fibrotic skin pathologies

Matrix Biol. 2013 Aug 8;32(6):325-31. doi: 10.1016/j.matbio.2013.02.010. Epub 2013 Mar 15.

Abstract

Skin fibrosis is characterized by activated fibroblasts and an altered architecture of the extracellular matrix. Excessive deposition of extracellular matrix proteins and altered cytokine levels in the dermal collagen matrix are common to several pathological situations such as localized scleroderma and systemic sclerosis, keloids, dermatosclerosis associated with venous ulcers and the fibroproliferative tissue surrounding invasively growing tumors. Which factors contribute to altered organization of dermal collagen matrix in skin fibrosis is not well understood. We recently demonstrated that cartilage oligomeric matrix protein (COMP) functions as organizer of the dermal collagen I network in healthy human skin (Agarwal et al., 2012). Here we show that COMP deposition is enhanced in the dermis in various fibrotic conditions. COMP levels were significantly increased in fibrotic lesions derived from patients with localized scleroderma, in wound tissue and exudates of patients with venous leg ulcers and in the fibrotic stroma of biopsies from patients with basal cell carcinoma. We postulate enhanced deposition of COMP as one of the common factors altering the supramolecular architecture of collagen matrix in fibrotic skin pathologies. Interestingly, COMP remained nearly undetectable in normally healing wounds where myofibroblasts transiently accumulate in the granulation tissue. We conclude that COMP expression is restricted to a fibroblast differentiation state not identical to myofibroblasts which is induced by TGFβ and biomechanical forces.

Keywords: Basal cell carcinoma; COMP; Cartilage oligomeric matrix protein; Chronic wounds; Collagen fibrils; ECM; ECM organization; Extracellular matrix; FACIT; Fibril-associated collagens with interrupted triple helices; Fibroplastic stroma response; TGFβ1; Transforming growth factor beta 1; alpha smooth muscle actin; αSMA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Carcinoma, Basal Cell / genetics
  • Carcinoma, Basal Cell / metabolism*
  • Carcinoma, Basal Cell / pathology
  • Cartilage Oligomeric Matrix Protein / genetics
  • Cartilage Oligomeric Matrix Protein / metabolism*
  • Case-Control Studies
  • Cell Differentiation
  • Cell Proliferation
  • Collagen Type I / genetics
  • Collagen Type I / metabolism
  • Dermis / metabolism*
  • Dermis / pathology
  • Extracellular Matrix / genetics
  • Extracellular Matrix / metabolism*
  • Extracellular Matrix / pathology
  • Fibroblasts / metabolism*
  • Fibroblasts / pathology
  • Fibrosis
  • Gene Expression Regulation
  • Humans
  • Leg Ulcer / genetics
  • Leg Ulcer / metabolism*
  • Leg Ulcer / pathology
  • Scleroderma, Localized / genetics
  • Scleroderma, Localized / metabolism*
  • Scleroderma, Localized / pathology
  • Signal Transduction
  • Skin Neoplasms / genetics
  • Skin Neoplasms / metabolism*
  • Skin Neoplasms / pathology
  • Wound Healing / physiology

Substances

  • COMP protein, human
  • Cartilage Oligomeric Matrix Protein
  • Collagen Type I